These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7559968)

  • 21. Antigenic diversity of Brazilian isolates of HoBi-like pestiviruses.
    Dias RK; Cargnelutti JF; Weber MN; Canal CW; Bauermann FV; Ridpath JF; Weiblen R; Flores EF
    Vet Microbiol; 2017 May; 203():221-228. PubMed ID: 28619148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of currently available bovine viral diarrhoea virus (BVDV) and HoBi-like pestivirus (HoBiPeV) specific diagnostic tests in detection of highly divergent HoBiPeVs in cattle.
    Moorthy D; Mishra N; Kalaiyarasu S; Jhade SK; Singh VP
    J Virol Methods; 2019 Oct; 272():113707. PubMed ID: 31351170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitopic characterisation of Turkish bovine viral diarrhoea virus (BVDV) isolates using monoclonal antibodies.
    Yeşilbağ K; Burgu I
    Acta Vet Hung; 2003; 51(2):237-44. PubMed ID: 12737051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of monoclonal antibodies to Brazilian isolates of bovine viral diarrhea virus.
    Kreutz LC; Donis R; Gil LH; Lima M; Hoffman AN; Garcez DC; Flores EF; Weiblen R
    Braz J Med Biol Res; 2000 Dec; 33(12):1459-66. PubMed ID: 11105099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response of cattle, persistently infected with noncytopathic BVDV, after superinfection with antigenically semi-homologous cytopathic BVDV.
    Bruschke CJ; Haghparast A; Hoek A; Rutten VP; Wentink GH; van Rijn PA; van Oirschot JT
    Vet Immunol Immunopathol; 1998 Mar; 62(1):37-50. PubMed ID: 9618867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).
    Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU
    Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A direct high-throughput in Cell-ELISA for measuring infectivity of cytopathic and non-cytopathic bovine viral diarrhoea virus strains applied to the assessment of antiviral activity.
    Quintana ME; Barone L; Forlenza MB; Trotta MV; Turco C; Mansilla FC; Cardoso NP; Capozzo AV
    J Virol Methods; 2018 Oct; 260():75-81. PubMed ID: 30031751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental induction of mucosal disease: consequences of superinfection of persistently infected cattle with different strains of cytopathogenic bovine viral diarrhea virus.
    Loehr BI; Frey HR; Moennig V; Greiser-Wilke I
    Arch Virol; 1998; 143(4):667-79. PubMed ID: 9638140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine viral diarrhea virus proteins: heterogeneity of cytopathogenic and non-cytopathogenic strains and evidence of a 53K glycoprotein neutralization epitope.
    Magar R; Minocha HC; Lecomte J
    Vet Microbiol; 1988 Apr; 16(4):303-14. PubMed ID: 2454527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity among bovine pestiviruses.
    Hamers C; Dehan P; Couvreur B; Letellier C; Kerkhofs P; Pastoret PP
    Vet J; 2001 Mar; 161(2):112-22. PubMed ID: 11243683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic relationships between Bovine viral diarrhea virus 1 and 2 and HoBi virus: possible impacts on diagnosis and control.
    Bauermann FV; Flores EF; Ridpath JF
    J Vet Diagn Invest; 2012 Mar; 24(2):253-61. PubMed ID: 22379042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple recombinant ELISA for the detection of bovine viral diarrhoea virus antibodies in cattle sera.
    Chimeno Zoth S; Taboga O
    J Virol Methods; 2006 Dec; 138(1-2):99-108. PubMed ID: 16963129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine viral diarrhea virus proteins and their antigenic analyses.
    Donis RO; Corapi WV; Dubovi EJ
    Arch Virol Suppl; 1991; 3():29-40. PubMed ID: 9210923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origination and consequences of bovine viral diarrhea virus diversity.
    Bolin SR; Grooms DL
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):51-68. PubMed ID: 15062474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of vaccination of seronegative bulls with modified-live, cytopathic bovine viral diarrhea viruses.
    Givens MD; Riddell KP; Zhang Y; Galik P; Walz PH; Brodersen BW; Johnson JW; Passler T; Widel P; Tremblay R
    Theriogenology; 2009 Apr; 71(6):975-83. PubMed ID: 19144395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The characterization of the neutralizing bovine viral diarrhea virus monoclonal antibodies and antigenic diversity of E2 glycoprotein.
    Kalaycioglu AT; Russell PH; Howard CR
    J Vet Med Sci; 2012 Sep; 74(9):1117-20. PubMed ID: 22673562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vaccination and challenge with bovine viral diarrhea virus (BVDV) of calves previously infected with a non-cytopathic BVDV.
    Castrucci G; Frigeri F; Ferrari M; Traldi V
    Comp Immunol Microbiol Infect Dis; 1991; 14(1):31-8. PubMed ID: 1647929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes.
    Fulton RW; Ridpath JF; Confer AW; Saliki JT; Burge LJ; Payton ME
    Biologicals; 2003 Jun; 31(2):89-95. PubMed ID: 12770537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.